Apriem Advisors’s Clorox CLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-1,683
| Closed | -$202K | – | 196 |
|
|
2025
Q2 | $202K | Sell |
1,683
-38
| -2% | -$5.07K | 0.02% | 184 |
|
|
2025
Q1 | $253K | Hold |
1,721
| – | – | 0.03% | 153 |
|
|
2024
Q4 | $279K | Sell |
1,721
-199
| -10% | -$32.6K | 0.03% | 150 |
|
|
2024
Q3 | $313K | Sell |
1,920
-140
| -7% | -$20.7K | 0.04% | 131 |
|
|
2024
Q2 | $281K | Sell |
2,060
-579
| -22% | -$80.4K | 0.03% | 140 |
|
|
2024
Q1 | $404K | Buy |
2,639
+1
| +0% | +$149 | 0.05% | 116 |
|
|
2023
Q4 | $376K | Sell |
2,638
-57
| -2% | -$7.6K | 0.05% | 109 |
|
|
2023
Q3 | $353K | Buy |
2,695
+1
| +0% | +$152 | 0.05% | 109 |
|
|
2023
Q2 | $428K | Sell |
2,694
-106
| -4% | -$17.1K | 0.06% | 106 |
|
|
2023
Q1 | $443K | Buy |
2,800
+49
| +2% | +$7.35K | 0.07% | 99 |
|
|
2022
Q4 | $386K | Buy |
2,751
+2
| +0.1% | +$284 | 0.07% | 103 |
|
|
2022
Q3 | $353K | Buy |
2,749
+81
| +3% | +$11.7K | 0.06% | 103 |
|
|
2022
Q2 | $376K | Buy |
2,668
+26
| +1% | +$3.71K | 0.06% | 101 |
|
|
2022
Q1 | $367K | Sell |
2,642
-805
| -23% | -$123K | 0.05% | 109 |
|
|
2021
Q4 | $601K | Buy |
3,447
+221
| +7% | +$36.8K | 0.09% | 87 |
|
|
2021
Q3 | $534K | Sell |
3,226
-39
| -1% | -$6.72K | 0.08% | 87 |
|
|
2021
Q2 | $587K | Buy |
3,265
+1,086
| +50% | +$198K | 0.09% | 83 |
|
|
2021
Q1 | $420K | Buy |
2,179
+186
| +9% | +$35.8K | 0.07% | 94 |
|
|
2020
Q4 | $402K | Buy |
1,993
+293
| +17% | +$60.6K | 0.07% | 87 |
|
|
2020
Q3 | $357K | Buy |
1,700
+205
| +14% | +$45.7K | 0.07% | 89 |
|
|
2020
Q2 | $328K | Sell |
1,495
-9,605
| -87% | -$1.92M | 0.07% | 89 |
|
|
2020
Q1 | $1.92M | Sell |
11,100
-36,551
| -77% | -$6.04M | 0.47% | 38 |
|
|
2019
Q4 | $7.32M | Sell |
47,651
-1,217
| -2% | -$182K | 1.4% | 24 |
|
|
2019
Q3 | $7.42M | Sell |
48,868
-2,363
| -5% | -$374K | 1.65% | 21 |
|
|
2019
Q2 | $7.84M | Buy |
51,231
+8,832
| +21% | +$1.35M | 2.46% | 14 |
|
|
2019
Q1 | $6.8M | Buy |
42,399
+9,314
| +28% | +$1.44M | 1.8% | 19 |
|
|
2018
Q4 | $5.1M | Buy |
33,085
+9,347
| +39% | +$1.46M | 1.79% | 18 |
|
|
2018
Q3 | $3.57M | Buy |
23,738
+23,625
| +20,907% | +$3.36M | 0.78% | 29 |
|
|
2018
Q2 | $15K | Buy |
+113
| New | +$13.9K | ﹤0.01% | 380 |
|
|
2017
Q2 | – | Sell |
-63
| Closed | -$8K | – | 203 |
|
|
2017
Q1 | $8K | Buy |
63
+33
| +110% | +$4.28K | ﹤0.01% | 433 |
|
|
2016
Q4 | $4K | Buy |
+30
| New | +$3.54K | ﹤0.01% | 526 |
|
Other funds holding CLX
Apriem Advisors's CLX Position: Q3 2025 in Review
Apriem Advisors sold out of Clorox (CLX) in Q3 2025, closing a stake of 1,683 shares — an estimated $202K sold.
Apriem Advisors first reported a position in CLX in Q4 2016 and held it in 31 quarters. The position peaked at $7.84M in Q2 2019. 1,092 funds tracked by Wall St. Rank hold CLX as of Q3 2025.
- Apriem Advisors reported no remaining Clorox position as of Q3 2025 after selling out during the quarter.
- Apriem Advisors sold 1,683 Clorox shares in Q3 2025, an estimated $202K.
- Apriem Advisors first reported a position in Clorox in Q4 2016 and held it in 31 quarters.
- Apriem Advisors's Clorox position peaked at $7.84M in Q2 2019.
- 1,092 funds tracked by Wall St. Rank held Clorox as of Q3 2025.
Based on Apriem Advisors's 13F filing for Q3 2025, filed 10 Nov 2025.